Načítá se...
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients
The introduction of tacrolimus in clinical practice has improved patient survival after organ transplant. However, despite the long use of tacrolimus in clinical practice, the best way to use this agent is still a matter of intense debate. The start of the genomic era has generated new research area...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Co., Limited
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3882390/ https://ncbi.nlm.nih.gov/pubmed/24409044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i48.9156 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|